Clinical staging of malignant pleural mesothelioma: current perspectives.

about

Staging in the era of international databases: documented improvements with remaining challenges.

P2860

Q54991391-1FDD69AE-7872-4372-8389-2E95A93F14BB

P2860

Clinical staging of malignant pleural mesothelioma: current perspectives.

Item

http://www.wikidata.org/entity/Q41522440

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Clinical staging of malignant pleural mesothelioma: current perspectives.

@en

type

Item

label

Clinical staging of malignant pleural mesothelioma: current perspectives.

@en

prefLabel

Clinical staging of malignant pleural mesothelioma: current perspectives.

@en

P1476

Clinical staging of malignant pleural mesothelioma: current perspectives.

@en

P2093

Alessandro Zanello

http://www.w3.org/2001/XMLSchema#string

Costantino De Filippis

http://www.w3.org/2001/XMLSchema#string

Egesta Lopci

http://www.w3.org/2001/XMLSchema#string

Eleonora Cerchiaro

http://www.w3.org/2001/XMLSchema#string

Giovanna Rizzardi

http://www.w3.org/2001/XMLSchema#string

Giovanni Luca Ceresoli

http://www.w3.org/2001/XMLSchema#string

Letizia Gianoncelli

http://www.w3.org/2001/XMLSchema#string

Luigi Bortolotti

http://www.w3.org/2001/XMLSchema#string

Maria Bonomi

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.

B7-H1 expression in malignant pleural mesothelioma is associated with sarcomatoid histology and poor prognosis.

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey.

Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.

A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.

Positron emission tomography predicts survival in malignant pleural mesothelioma.

Validation of genomics-based prognostic tests in malignant pleural mesothelioma.

P304

127-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/LCTT.S102113

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28860886

http://www.w3.org/2001/XMLSchema#string

P932

5571821

http://www.w3.org/2001/XMLSchema#string

Clinical staging of malignant pleural mesothelioma: current perspectives.

about

P2860

P2860

Clinical staging of malignant pleural mesothelioma: current perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932